Multiple pulse extended release formulations of clindamycin

• US 20030129236A1
• Filed: 12/19/2002
• Published: 07/10/2003
• Est. Priority Date: 12/20/2001
• Status: Abandoned Application

• Current Assignee: Pharmacia Corporation (Pfizer Inc.)
• Original Assignee: Pharmacia Corporation (Pfizer Inc.)
• Inventors: Cox, Steven R., Ganorkar, Loksidh D., Lee, Ernest J., Heimlich, John M., Noack, Robert M., VerHage, Ronald R.
• Application Number:
  US10/324,718
• Publication Number:
  US 20030129236A1
• Time in Patent Office: Days
• US Class Current: 424/470
• CPC Class Codes: A61K 9/2054 Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
• CPC Class Codes: A61K 9/2077 Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
• CPC Class Codes: A61K 9/2866 Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

The present invention is directed to an oral dosage form for multiple-pulsed delivery of at least two fractions of clindamycin to a subject, one in an immediate-release form and the other in an extended release form. The oral dosage forms of the present invention provide a means for treating or preventing gram-positive bacterial infections with a minimal number of treatments per day, potentially, as little as once or twice per day.

Claims

1. An extended release composition, comprising a first fraction of clindamycin released in a first pulse, within about thirty minutes of oral administration of the composition to a subject, and a second fraction of clindamycin released in a second pulse, about 4 hours to about 15 hours after oral administration of the composition to the subject.

2. The extended release composition of claim 1, wherein the second fraction of clindamycin is released into the colon of the subject.

3. The extended release composition of claim 1, comprising a tablet in a capsule, wherein the tablet is coated with a functional coating.

4. The extended release composition of claim 3, the tablet further comprising swellable excipients that promote pulsed release of clindamycin by swelling rupture of the functional coating.

5. The extended release composition of claim 3, the tablet further comprising effervescent agents that promote pulsed release of clindamycin by effervescent rupture of the functional coating.

6. The extended release composition of claim 1, wherein the second fraction of clindamycin is present as microparticles, in a form selected from the group consisting of compressed pellets, extruded beads, and spray dried beads.

7. The extended release composition of claim 6, wherein the microparticles are coated.

8. The extended release composition of claim 7, wherein the microparticles further comprise swellable excipients that promote pulsed release of clindamycin by swelling rupture of the microparticle coating.

9. The extended release composition of claim 7, wherein the microparticles further comprise effervescent agents that promote pulsed release of clindamycin by effervescent rupture of the microparticle coating.

10. The extended release composition of claim 7, wherein the microparticle coating is solubilized at a certain pH.

11. The extended release composition of claim 1, wherein the second fraction of clindamycin is contained within beads coated with a release-extending polymer coating.

12. The extended release composition of claim 11, the release-extending polymer coating is selected from the group consisting of:

hydroxypropylcellulose, hydroxyethylcellulose, methylhydroxyethylcellulose, methylcellulose, ethylcellulose, cellulose acetate, sodium carboxymethylcellulose, polymers and copolymers of acrylic acid and methacrylic acid and esters thereof.

13. The extended release composition of claim 11, wherein the release-extending polymer coating further comprises a water-soluble substance that forms pores or channels in the coating after oral administration of the composition to a subject.

14. The extended release composition of claim 11, further comprising a suspension of the first fraction of clindamycin and a disintegrant spray coated onto the release-extending polymer coating of the beads.

15. The extended release composition of claim 11, wherein the release-extending polymer coating comprises a water-soluble substance that forms pores or channels in the coating after oral administration of the composition to a subject.

16. The extended release composition of claim 11, further comprising a suspension of the first fraction of clindamycin and a disintegrant spray coated onto the release-extending polymer coating of the beads.

17. The extended release composition of claim 1, wherein the first fraction of clindamycin and the second fraction, of clindamycin are independently is selected from the group consisting of clindamycin HCl, clindamycin phosphate, clindamycin palmitate, and clindamycin crystalline free base.

18. The extended release composition of claim 1, the first fraction of clindamycin and the second fraction of clindamycin both comprising clindamycin HCl.

19. An extended release composition, comprising a first fraction of clindamycin HCl released in a first pulse, within about thirty minutes of oral administration of the composition to a subject, and a second fraction of clindamycin HCl released at least 12 hours after oral administration to the subject.

20. The extended release composition of claim 19, comprising a tablet in a capsule, wherein the tablet is coated with a functional coating.

21. The extended release composition of claim 20, the tablet further comprising swellable excipients that promote pulsed release of clindamycin by swelling rupture of the functional coating.

22. The extended release composition of claim 20, the tablet further comprising effervescent agents that promote pulsed release of clindamycin by effervescent rupture of the functional coating.

23. The extended release composition of claim 19, wherein the second fraction of clindamycin is present as microparticles, in a form selected from the group consisting of compressed pellets, extruded beads, and spray dried beads.

24. The extended release composition of claim 23, wherein the microparticles are coated.

25. The extended release composition of claim 23, wherein the microparticles further comprise swellable excipients that promote pulsed release of clindamycin by swelling rupture of the microparticle coating.

26. The extended release composition of claim 23, wherein the microparticles further comprise effervescent agents that promote pulsed release of clindamycin by effervescent rupture of the microparticle coating.

27. The extended release composition of claim 23, wherein the microparticle coating is solubilized at a certain pH.

28. The extended release composition of claim 19, wherein the second fraction of clindamycin is contained within beads coated with a release-extending polymer coating.

29. The extended release composition of claim 28, the release-extending polymer coating is selected from the group consisting of:

hydroxypropylcellulose, hydroxyethylcellulose, methylhydroxyethylcellulose, methylcellulose, ethylcellulose, cellulose acetate, sodium carboxymethylcellulose, polymers and copolymers of acrylic acid and methacrylic acid and esters thereof.

30. The extended release composition of claim 28, wherein the release-extending polymer coating further comprises a water-soluble substance that forms pores or channels in the coating after oral administration of the composition to a subject.

31. The extended release composition of claim 28, further comprising a suspension of the first fraction of clindamycin and a disintegrant spray coated onto the release-extending polymer coating of the beads.

32. The extended release composition of claim 28, wherein the release-extending polymer coating comprises a water-soluble substance that forms pores or channels in the coating after oral administration of the composition to a subject.

33. The extended release composition of claim 28, further comprising a suspension of the first fraction of clindamycin and a disintegrant spray coated onto the release-extending polymer coating of the beads.